Industry Educational Session - Advanced CTCL: Integrating Risk Stratification to inform treatment decisions- Sponsored by Kyowa kirin
Tracks
-
| Monday, April 20, 2026 |
| 11:20 AM - 11:50 AM |
| Room 11B & C, Upper Level |
Details
Prof Scarisbrick - 10 mins
Introduction & PROCLIPI registry overview (scale, design, strengths, limitations)
Overall Survival in advanced cohort
CLIPI prognostic index
Dr Wendy Osborne – 10 mins
Overview of key systemic treatment options (guideline-based)
Where therapies informed by PROCLIPI fit in – review of key published data
Integrating systemic therapy with allo-SCT in the treatment pathway (when to refer, transplant readiness markers, early MDT discussion)
10 mins - Q & A
Speaker
Prof. Julia Scarisbrick
Consultant Dermatologist
University Hospitals Birmingham NHS Foundation Trust
Speaker One
Julia leads the Cutaneous Lymphoma Service within the Rare Diseases Centre at University Hospital Birmingham and Professor of Dermatology holding an Honorary Chair at the Institute of Immunology and Immunotherapy, University of Birmingham, UK. She is President of the International Society of Cutaneous Lymphomas (ISCL). Past Chair of the EORTC Cutaneous Lymphoma Taskforce and Trustee of the UK Photopheresis Society. Julia is active in both clinical and molecular research fields for cutaneous lymphoma. She has a sucessful translational research program and is involved in the development and delivery of both commercial and academic clinical studies. She has published over 150 peer-reviewed articles, contributed to a number of books, and is involved in the development of management guidelines.
Dr. Wendy Osborne
Consultant Haematologist
Freeman Hospital Newcastle
Speaker Two
Dr Wendy Osborne is a Consultant Haematologist at the Freeman Hospital, Newcastle. She graduated with First Class Honours from Newcastle University in 1998. Dr Osborne is Past-Chair of the British Society of Haematology Lymphoma Special Interest Group, a member of the UK Lymphoma Research Group, a medical advisor for the patient charity Lymphoma Action and is on the Executive Committee of the EHA Lymphoma Specialized Working Group. Dr Osborne is the Haematology Research Lead in Newcastle and a Chief Investigator and Principal Investigator for numerous clinical trials. Dr Osborne is an Honorary Senior Clinical Lecturer at Newcastle University and the teaching lead for the haematology undergraduate programme.